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Abstract
Background: The Joint Committee on Infant Hearing (JCIH) of the American Academy of Pediatrics recommends targeted 
surveillance of at-risk infants using a risk factor registry, in conjunction with parent and/or professional monitoring to de-
tect hearing loss that develops after newborn hearing screening. However, criticisms of these recommendations are emerg-
ing as targeted surveillance programs are costly, resource intensive, have poor follow-up rates, and lack evidence of best prac-
tice. The purpose of the current paper is to provide recommendations for risk factor registries incorporated within targeted 
surveillance programs.
Methods: Recommendations provided in this document were developed by combining the results of previous research, done 
with a systematic review of the literature, together with a comprehensive evaluation of a targeted surveillance program in 
Queensland, Australia.
Results: Recommendations are as follows. Children with the risk factors of family history or craniofacial anomalies should 
have their hearing monitored, whereas children with the risk factor of low birth weight should not. Children with the risk fac-
tors of syndrome or prolonged ventilation should potentially have their hearing monitored; however, the evidence is not defin-
itive. Equally, children with bacterial meningitis, hyperbilirubinemia, or professional concern as a risk factor may potentially 
not need their hearing monitored, but again the evidence is not definitive. For the risk factors of severe asphyxia and congen-
ital infection, the evidence was inconclusive and/or conflicting, so no recommendations are made.
Conclusion: More research is needed to further inform evidence-based clinical policy recommendations for hearing loss de-
tection in early childhood.
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Abbreviations: ABR – auditory brainstem response; CMV – cytomegalovirus; DPOAEs – distortion product otoacoustic emis-
sions; ECMO – extracorporeal membrane oxygenation; HIE – hypoxic ischemic encephalopathy; HIV – human immunode-
ficiency virus; HVDT – health visitor distraction test; JCIH – Joint Committee on Infant Hearing; LBW – low birth weight; 
NHMRC – National Health and Medical Research Council (Australia); PPHN – persistent pulmonary hypertension of the 
newborn; TEOAEs – transient evoked otoacoustic emissions; UNHS – universal newborn hearing screening; VRA – visual 
reinforcement audiometry.
RECOMENDACIONES PARA SEGUIMIENTO DE AUDICIÓN EN NIÑOS 
UTILIZANDO UN REGISTRO DE FACTORES DE RIESGO
Extracto
Antecedentes: El Comité Conjunto sobre Audición Infantil (the Joint Committee on Infant Hearing – JCIH) de la Academia 
Americana de Pediatría (the American Academy of Pediatrics) recomienda una vigilancia específica de los niños en situación 
de riesgo utilizando un registro de factores de riesgo, junto con supervisión por los padres y/o supervisión profesional para de-
tectar la pérdida de audición que se desarrolla después de screening auditivo neonatal. Sin embargo, aparecen críticas de estas 
recomendaciones, ya que los programas específicos de vigilancia son costosos, requieren muchos recursos, tienen bajas tasas 
de seguimiento y carecen de evidencia de buenas prácticas. El propósito del presente trabajo es proporcionar recomendaciones 
para los registros de los factores de riesgo incorporadas en los programas de vigilancia específicos.
Métodos: Las recomendaciones proporcionadas en este documento se han elaborado mediante la combinación de los resulta-
dos de la investigación anterior, realizada con una revisión sistemática de la literatura, con una evaluación integral de un pro-
grama de vigilancia específico realizado en Queensland, Australia.
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Resultados: Las recomendaciones son las siguientes: Los niños con los factores de riesgo de la historia familiar o anomalías 
craneofaciales requieren seguimiento de su audiencia, mientras que los niños con el factor de riesgo de bajo peso al nacer no lo 
requieren. Los niños con los factores de riesgo de ventilación prolongada o de síndrome potencialmente requieren seguimien-
to de su audiencia, sin embargo, las pruebas no son definitivas. Igualmente, en el caso de factores de riesgo siendo meningitis 
bacteriana, hiperbilirrubinemia o preocupación profesional, los niños potencialmente pueden no necesitar seguimiento de su 
audiencia, pero en este caso las pruebas tampoco son definitivas. Para los factores de riesgo de asfixia severa e infección con-
génita, las pruebas no fueron concluyentes y/o fueron contradictorias, por lo que no se hacen recomendaciones.
Conclusión: Se necesita más investigación para elaborar recomendaciones para políticas clínicas basadas en pruebas para de-
tección de pérdida de audición en la infancia temprana.
Palabras claves: vigilancia • factores de riesgo • seguimiento • pérdida de audición postnatal • niños
Abreviaturas: ABR – respuesta auditiva del tronco encefálico; CMV – citomegalovirus; DPOAE – emisiones otoacústicas por 
productos de distorsión; ECMO – oxigenación por membrana extracorpórea; HIE – encefalopatía hipóxico-isquémica; VIH – 
virus de la inmunodeficiencia humana; HVDT – test de distracción por visitador médico; JCIH – Comité Conjunto sobre Au-
dición Infantil; LBW – bajo peso al nacer; NHMRC – Consejo Nacional de Salud e Investigaciones Médicas (Australia); PPHN 
– hipertensión pulmonar persistente del recién nacido; TEOAEs – otoemisiones acústicas evocadas transitorias; UNHS – scree-
ning auditivo neonatal universal; VRA – audiometría de refuerzo visual.
РЕКОМЕНДАЦИИ ПО ПРОВЕРКЕ СЛУХА У ДЕТЕЙ C ИСПОЛЬЗОВАНИЕМ 
РЕГИСТРАЦИИ ФАКТОРОВ РИСКА
Резюме
Предпосылки: Комитет по проблемам слуха у грудных детей американской академии педиатров рекоменду-
ет целенаправленное наблюдение новорожденных из группы риска с помощью регистрации факторов риска, в 
сочетании с наблюдением родителей и/или профессионалистов, чтобы выявлять потерю слуха, которая разви-
вается после всеобщего тестирования слуха новорожденных. Однако, появляется критика этих рекомендаций, 
подчеркивующая, что программы целенаправленного наблюдения дорогие, требующие больших средств, име-
ют низкий предел проверки исполнения, и не имеется доказательств из самой лучшей практики. Цель этой ис-
следовательской работы – предоставить рекомендации по регистрации факторов риска, внедренные в програм-
мы целенаправленного наблюдения.
Методы: Предоставленные в этой работе рекомендации разработаны путем сочетания результатов предыдуще-
го исследования, выполненного при систематическом обзоре литературы, с обширной оценкой программы це-
ленаправленного наблюдения в Квинсленде, Австралия.
Результаты: Имеются следующие рекомендации. Дети с факторами риска семейной истории или с черепно- ли-
цевыми пороками должны проходить проверку слуха, дети с фактором риска низкого веса во время рождения 
– нет. Дети с фактором риска синдрома или продолжительных дыхательных расстройств потенциально долж-
ны проходить проверку слуха; однако решающие доказательства не получены. Также дети с с факторами риска 
бактериального менингита и гипербилирубинемии потенциально могут не требовать проверки слуха, но, снова, 
решающие доказательства не получены. При факторе риска тяжелой асфиксии и врожденной инфекции, доказа-
тельства были нерешающими и/или противоречивыми, поэтому никаких рекомендаций не имеется.
Заключение: Для дальнейших информационных, основанных на доказательствах, клинических рекомендаций 
по выявлению потери слуха в раннем детстве требуется больше исследований.
Ключевые слова: наблюдение • факторы риска • из группы риска • проверка • постнатальная потеря слуха • дети
Сокращения: ABR – слуховой стволомозговой ответ; CMV – цитомегаловирус; DPOAEs – отоакустические эмис-
сии на частоте продукта искажения; ECMO – экстракорпоральная мембранная оксигенация; HIE – гипоксиче-
ская ишемическая энцефалопатия; ВИЧ – вирус иммунодефицита человека; HVDT – слуховой тест по опреде-
лению места происхождения звука; JCIH – комитет по проблемам слуха у грудных детей; LBW – низкий вес при 
рождении; NHMRC – Совет национального здравоохранения и медицинских исследований (Австралия); PPHN 
– легочная гипертензия при системной склеродермии новорожденного; TEOAEs – методы вызванной задержан-
ной отоакустической эмиссии; UNHS – всеобщее тестирование слуха новорожденных; VRA – аудиометрия с ви-
зуальным подкреплением.
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Background
The Joint Committee on Infant Hearing (JCIH) of the 
American Academy of Pediatrics recommends targeted 
surveillance as the primary method to monitor hearing 
in children who may be at risk of developing a postnatal 
hearing loss [1]. The most recent guidelines outlined in the 
JCIH 2007 Position Statement identified 11 risk factor cate-
gories associated with hearing loss, and any child that pre-
sents with one of these factors during universal newborn 
hearing screening (UNHS) or in the medical home dur-
ing early well-infant visits should have at least one audio-
logical assessment by 24 to 36 months of age. On the JCIH 
risk factor registry, eight individual risk factors are marked 
as a greater concern for delayed-onset hearing loss. These 
include caregiver concerns, family history, extracorporeal 
membrane oxygenation (ECMO), cytomegalovirus (CMV), 
syndromes associated with progressive hearing loss, neuro-
degenerative disorders, culture-positive postnatal infections 
associated with sensorineural hearing loss, and chemothera-
py. It is recommended that any child that presents with one 
of these risk factors have more frequent audiological assess-
ments throughout early childhood. In addition to risk fac-
tor monitoring, the JCIH recommends the family doctor 
monitor auditory skills, developmental milestones, and mid-
dle ear status in all children and should consider caregiv-
er concerns about the child’s speech and language abilities.
Although these recommendations are proposed by the 
JCIH, many targeted surveillance programs are only loose-
ly basing their programs on these recommendations due 
to significant criticisms against risk factor registries. Crit-
icisms associated with targeted surveillance programs in-
clude the lack of evidence for the majority of the risk fac-
tors on the JCIH registry in detecting postnatal hearing 
loss [2], the large number of children without risk factors 
who develop a postnatal hearing loss [3,4], the lack of pa-
rental co-operation in providing risk factors and attend-
ing appointments [5,6], and the difficulties in behaviour-
ally identifying hearing loss in young children [7,8]. As 
many programs are failing to abide by the JCIH recom-
mendations, there is a lack of consistency across targeted 
surveillance programs in regards to risk factors used and 
frequency of audiology appointments [2].
This article is the final in a series of four publications which 
have addressed the evidence for targeted surveillance pro-
grams using a risk factor registry. The outcomes of the pre-
vious three studies are combined in this publication to ar-
rive at formal recommendations for risk factor registries.
The first study in the series [2] was a systematic literature 
review that investigated the literature for evidence-based 
support for targeted surveillance programs using a risk fac-
tor registry. The literature search was conducted in the da-
tabases of Medline, CINAHL, and EMBASE, with relevant 
publications from 1973 to March 2011 accessed so that the 
changing processes and techniques for detecting postnatal 
hearing loss would be adequately represented. Reference 
lists of key publications and expert committee papers were 
also inspected for any additional publications. In total, 40 
articles met the inclusion criteria and were included in the 
review. Outcomes of the review revealed that CMV, ECMO, 
congenital diaphragmatic hernia, and persistent pulmonary 
hypertension of the newborn were associated with postna-
tal hearing loss, whereas preauricular skin tags and ear pits, 
low birth weight (LBW), and toxoplasmosis were not. The 
review also identified that second-phase universal screening 
programs, CMV screening, and genetic screening should 
be explored as potential additions or alternatives to target-
ed surveillance using risk factors. It was also noted that the 
conclusions drawn from the review should be treated with 
caution as many of the publications included small sample 
sizes and were mainly based at a single site only. Overall, 
this study highlighted the significant gaps in the literature 
for risk factors and postnatal hearing loss and emphasised 
the need for further research in this area.
The second study [9] was an evaluation of a targeted surveil-
lance program using a risk factor registry that is currently 
operating in Queensland, Australia. The UNHS and target-
ed surveillance program was introduced to Queensland in 
September 2004, with full implementation achieved by De-
cember 2006. The risk factors incorporated in the UNHS 
and targeted surveillance program in Queensland are giv-
en in Table 1. Most children referred for targeted surveil-
lance are seen at audiology for a one-off appointment at 9 
to 12 months old with the exception of children who have 
family history or congenital infection as a risk factor. Chil-
dren with family history as a risk factor are seen at 6 months 
old, then every 6 months until 2 years old, with a discharge 
assessment performed at 3 years old. Children with con-
genital infection as a risk factor are seen at 3 months old, 
6 months old, and then every 6 months until 2 years old. 
Assessments performed at these appointments depend on 
the child’s age and developmental level and include otos-
copy, tympanometry, auditory brainstem response (ABR), 
visual reinforcement audiometry (VRA), transient evoked 
otoacoustic emissions (TEOAEs), distortion product otoa-
coustic emissions (DPOAEs), and play audiometry. Chil-
dren are discharged from the targeted surveillance pro-
gram when they have completed their appointment series 
and frequency-specific information has been obtained for 
each ear. For the study period of September 2004 to De-
cember 2009, 7,320 children (2.8% of 261,328) were referred 
to the targeted surveillance program, of which 56 (0.77%) 
were identified with a postnatal hearing loss. The risk fac-
tors present in the children referred for targeted surveil-
lance as well as those who developed a postnatal hearing 
loss are given in Table 2. For the children referred for tar-
geted surveillance, the largest proportion of referrals were 
generated from family history (40.5%), LBW (31.6%), and 
prolonged ventilation (25.0%). For the risk factors reported 
in children who developed a postnatal hearing loss, 46.4% 
reported family history as a risk factor, and 19.6% report-
ed a syndrome or prolonged ventilation as a risk factor.
Another major finding of this study was the high ‘lost con-
tact’ rate of 32.4% reported for the surveillance program. 
Investigation of risk factors present in children who did 
not attend revealed that children with one risk factor were 
significantly more likely to not attend a surveillance ap-
pointment [χ2(1)=29.4, p<0.001] when compared to chil-
dren with more than one risk factor. Investigation of risk 
factors in these children revealed that children with the risk 
factors of family history [χ2(1)=33.9, p<0.001] and congen-
ital infection [χ2(1)=4.3, p=0.037] were significantly over-
represented in the lost contact cohort when compared to 
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children originally referred with these risk factors (e.g., 
family history constituted 50.0% of the original referrals in 
children with one risk factor but 56.9% of the lost contact 
cohort) (see Table 2). Although findings from this program 
evaluation indicated that the targeted surveillance program 
was successful in detecting postnatal hearing loss, the high 
lost contact rates, the significant number of children with 
on-going monitoring appointments, the delays in first as-
sessment, and the extensive diagnostic testing undertak-
en for all children referred for targeted surveillance ques-
tioned the effectiveness of risk factor monitoring.
The third study [10] used a subset of the cohort from the 
second study and focused primarily on the risk factors 
in children who had completed their appointment series 
according to Queensland Health protocol and were dis-
charged from the targeted surveillance program. The goal 
of this study was to investigate the risk factors that were 
most likely to predict the occurrence of postnatal hearing 
loss using a formal analysis. Major outcomes of this study 
were that the risk factors of family history and craniofa-
cial anomalies predicted the occurrence of postnatal hear-
ing loss, whereas LBW did not.
The purpose of the current paper is to provide recom-
mendations for risk factor registries incorporated within 
targeted surveillance programs using the information de-
rived from the previous three studies. By combining the 
1 Family history of permanent childhood hearing loss (mother/father/siblings of baby only) excluding grommets/ear infections/trauma
2 Syndromes associated with hearing loss (e.g., Down syndrome, FAS)
3 Prolonged ventilation ≥5 days (IPPV/CPAP)
4 Bacterial meningitis (confirmed/suspected)
5 Low birth weight ≤1500 grams
6 Severe asphyxia at birth (convulsions/HIE/PPHN)
7 Craniofacial anomalies (e.g., cleft palate – excluding cleft lip and skin tags)
8 Hyperbilirubinemia levels ≥450 µmol/L (term) or ≥340 µmol/L (preterm)
9 Proven/suspected congenital infection of the baby (toxoplasmosis, rubella, CMV, herpes, syphilis)
10 Professional concern
Table 1.  Risk factor registry used by Queensland’s universal newborn hearing screening (UNHS) and targeted surveil-
lance program [10].
FAS – fetal alcohol syndrome; IPPV – intermittent positive pressure ventilation; CPAP – continuous positive airway 
pressure; HIE – hypoxic ischemic encephalopathy; PPHN – persistent pulmonary hypertension of the newborn; CMV 
– cytomegalovirus.
Individual 
risk factors
Referrals for targeted 
surveillance 
n=7320
Postnatal 
hearing loss 
n=56
Risk factors in 
children with one 
risk factor only 
n=5659
Risk factors in 
children with one 
risk factor only who 
became ‘lost contact’ 
n=1360
Family history  2968 (40.5%)  26 (46.4%)  2831 (50.0%)  774 (56.9%)
Syndrome  353 (4.8%)  11 (19.6%)  259 (4.6%)  27 (2.0%)
Prolonged ventilation  1833 (25.0%)  11 (19.6%)  398 (7.0%)  82 (6.0%)
Bacterial meningitis  68 (0.9%)  0 (0%)  41 (0.7%)  2 (0.2%)
Low birth weight  2310 (31.6%)  4 (7.1%)  948 (16.8%)  235 (17.3%)
Severe asphyxia  591 (8.1%)  9 (16.1%)  353 (6.3%)  70 (5.2%)
Craniofacial anomalies  588 (8.0%)  10 (17.9%)  319 (5.6%)  56 (4.1%)
Hyperbilirubinemia  334 (4.6%)  2 (3.6%)  267 (4.7%)  52 (3.8%)
Congenital infection  244 (3.3%)  2 (3.6%)  169 (3.0%)  52 (3.8%)
Professional concern  78 (1.1%)  0 (0%)  74 (1.3%)  10 (0.7%)
Table 2.  Risk factors present in all children enrolled for targeted surveillance, children who developed a postnatal hearing 
loss, and children who became ‘lost contact’ [9].
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information obtained from these studies, a better under-
standing of the relationship between risk factors and post-
natal hearing loss can occur, which will help inform evi-
dence-based, clinical policy recommendations for hearing 
loss surveillance in infants transnationally and beyond.
Recommendations for risk factors incorporated 
in a risk factor registry
Listed below are recommendations supporting or oppos-
ing monitoring, within a targeted surveillance program, 
of children who have each risk factor. Each recommenda-
tion is given an overall grading based on the available evi-
dence (see Table 3). This grading system was based on the 
Australian National Health and Medical Research Council 
(NHMRC) levels of evidence and grades of recommenda-
tion [11]. In general, where the evidence is clear and in fa-
vour of monitoring, the recommendation is scored as ‘Grade 
A: Monitor’. Grade A recommendations are worded to in-
clude the word “should” to indicate that monitoring of chil-
dren with this risk factor should occur. When the collective 
evidence provides support for not monitoring a particu-
lar risk factor, the recommendation is scored as ‘Grade E: 
Don’t Monitor’ and the wording in the recommendation is 
“should not”. For recommendations graded as B and D, the 
evidence is less clear and this is reflected in the wording of 
the recommendation, i.e., ‘Potentially Monitor’ and ‘Poten-
tially Don’t Monitor’. Where there is a lack of evidence or 
mixed/inconclusive evidence to support or oppose moni-
toring, the recommendation is scored as ‘Grade C: Lack of 
Evidence’. Currently, there is only sufficient support to rec-
ommend monitoring for risk factors graded A and B only.
Family history of permanent childhood hearing 
loss (mother/father/siblings of baby only) exclud-
ing grommets/ear infections/trauma
Outcomes of the systematic literature review: The sys-
tematic literature review revealed three studies [12–14] that 
reported on children with postnatal hearing loss and fam-
ily history as a risk factor. However, the evidence provided 
by these studies was insufficient as it was difficult to es-
tablish the exact nature of the relationship between fam-
ily history and the advent of postnatal hearing loss given 
that: (i) children with a hearing loss only were included 
(i.e., children without postnatal hearing loss were not in-
cluded); or (ii) the children who developed a postnatal 
hearing loss had more than one risk factor.
Outcomes of the analysis of Queensland’s targeted sur-
veillance program: Analysis of Queensland’s targeted sur-
veillance program provided support in favor of monitoring 
children with family history as a risk factor. Family his-
tory was the most frequently reported risk factor in chil-
dren with a postnatal hearing loss, with 46.4% (26/56) of 
children having this risk factor. A positive yield of 5.3% 
(26/494) was calculated for children with family histo-
ry who had completed their appointment series. Further 
formal analysis on these children revealed a positive sig-
nificant correlation between family history and postnatal 
hearing [χ2(1)=16.9, p<0.001]. Logistic regression analysis 
was also completed and revealed that children with fami-
ly history as a risk factor were almost twice more likely to 
develop a postnatal hearing loss than those without fam-
ily history as a risk factor (OR: 1.92; 95% CI: 1.04–3.56). 
Recommendation (a): Children with 
family history as a risk factor should have 
their hearing monitored throughout early 
childhood.
Grade A: 
Monitor
Syndromes associated with hearing loss (e.g., Down, 
fetal alcohol syndrome)
Outcomes of the systematic literature review: Limited 
evidence was obtained from the systematic literature re-
view for syndromes and postnatal hearing loss, with only 
one child identified with the risk factor of syndrome who 
passed newborn hearing screening who subsequently de-
veloped a postnatal hearing loss. This child had Bran-
chio-oto-renal syndrome as well as preauricular skin tags 
and pits [15].
Grade Recommendation Description
A
Monitor Collective evidence generally offers strong support for monitoring. 
For example, existence of cohort studies indicating cases of postnatal 
hearing loss in children with the risk factor in isolation + a positive yield 
+ positive relationship/significant Chi-squared correlation + OR>1
B
Potentially Monitor Overall findings are mixed; however, some or most indicate support for 
monitoring as per grading A
C
Lack of Evidence Collective evidence is lacking. For example, no literature evidence or 
case studies only; +/– presence of complicating risk factors; and/or 
logistic regression not completed. Alternatively, overall findings may be 
highly mixed/inconclusive
D
Potentially Don’t Monitor Overall findings are mixed; however, some or most indicate support for 
not monitoring as per grading E
E
Don’t Monitor Collective evidence generally offers strong support for not monitoring. 
For example, existence of cohort studies indicating no/limited cases of 
postnatal hearing loss and complicating risk factors present + nil yield 
+ negative relationship/insignificant Chi-squared correlation + OR≤1
Table 3.  Levels of evidence for recommendations based on the Australian National Health and Medical Research Council 
(NHMRC) levels of evidence [11].
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Outcomes of the analysis of Queensland’s targeted sur-
veillance program: The outcomes of the analysis of Queens-
land’s targeted surveillance program indicated promising 
results in favor of monitoring children with a syndrome. 
For children diagnosed with a postnatal hearing loss, 19.6% 
(11/56) had syndrome as a risk factor. Syndrome had the 
highest yield calculation of all the risk factors, with 12.0% 
(11/92) of children with a syndrome who had completed 
their appointment series having developed a postnatal hear-
ing loss. Results from chi-squared analysis revealed a pos-
itive significant correlation between syndrome and post-
natal hearing loss [χ2(1)=32.2, p<0.001]. Further analysis 
using logistic regression was unable to be completed due 
to issues of multicollinarity with craniofacial anomalies.
Recommendation (b): Children with 
syndrome as a risk factor should potentially 
have their hearing monitored throughout 
early childhood.
Grade B: 
Potentially 
Monitor
Prolonged ventilation ≥5 days
Outcomes of the systematic literature review: Although 
the systematic literature review identified several studies 
that reported on children with postnatal hearing loss who 
had received ventilation, it was difficult to establish the ex-
act nature of the relationship between ventilation and post-
natal hearing loss given that the children with postnatal 
hearing loss had other complicating risk factors. Other risk 
factors present in these children include respiratory dis-
tress syndrome [16,17], congenital diaphragmatic hernia 
[18], asphyxia [13], and family history [12,13].
The systematic literature review also identified five publica-
tions on children who had received ECMO and developed 
a postnatal hearing loss. ECMO is often used post cardi-
ac surgery when all other forms of conventional ventila-
tion have failed. Four of the five studies reported similar 
findings, with 8.1% [19] to 12.6% [20] of the cohort who 
had received ECMO developing a postnatal hearing loss.
Outcomes of the analysis of Queensland’s targeted sur-
veillance program: Analysis of Queensland’s targeted sur-
veillance program indicated promising results in favor of 
monitoring children, with 19.6% (11/56) of children with a 
postnatal hearing loss having prolonged ventilation as a risk 
factor. The yield calculation for children with the risk factor 
prolonged ventilation who had completed their appointment 
series was 1.5% (11/738). Results from chi-squared analysis 
revealed a significant correlation between prolonged ventila-
tion and postnatal hearing loss [χ2(1)=6.0, p=0.014]. Further 
analysis on the risk factor prolonged ventilation was unable 
to be completed due to issues of multicollinarity with LBW.
At the time of this study, ECMO was not performed in 
Queensland. 
Recommendation (c): Children with 
prolonged ventilation as a risk factor 
should potentially have their hearing 
monitored throughout early childhood. 
In addition to prolonged ventilation, if 
ECMO is used then the child should have 
their hearing monitored throughout early 
childhood.
Grade B: 
Potentially 
Monitor
Bacterial meningitis (confirmed/suspected)
Outcomes of the systematic literature review: The in-
clusion criteria for studies in the systematic literature re-
view were that the neonates needed to have passed new-
born hearing screening/audiology assessment at birth and 
that risk factor/s needed to be reported during the new-
born hearing screening period (birth through age 28 days 
consistent with the JCIH guidelines). These criteria were 
used, since the literature review was designed to examine 
the evidence for targeted surveillance using a risk factor 
registry in detecting postnatal hearing loss. As a result of 
these criteria, a substantial amount of literature associat-
ed with bacterial meningitis was eliminated from the sys-
tematic literature review. For the two studies included in 
the systematic literature review which had cases of chil-
dren with bacterial meningitis who developed a postna-
tal hearing loss [13,14], it was difficult to establish the ex-
act nature of the relationship between bacterial meningitis 
and postnatal hearing loss given that only children with 
a hearing loss were included in the study and additional 
risk factors were present in these cases.
Outcomes of the analysis of Queensland’s targeted sur-
veillance program: Information obtained from analysis of 
Queensland’s targeted surveillance program was also lim-
ited. For the 68 children referred for targeted surveillance 
with bacterial meningitis identified at the birth screen, 
no children were identified with a postnatal hearing loss 
(nil yield). Further, no significant correlation was found 
between postnatal hearing loss and bacterial meningitis. 
Analysis of cases of postnatal hearing loss that were in-
cidentally identified and reported to the Healthy Hearing 
program revealed that two children developed a hearing 
loss subsequent to bacterial meningitis during childhood. 
These children were assessed as a result of a medical re-
ferral rather than through the targeted surveillance pro-
gram as they contracted bacterial meningitis following the 
newborn hearing screening period. Therefore, these cas-
es of postnatal hearing loss were excluded from the anal-
ysis of the targeted surveillance program. 
Recommendation (d): Children with 
bacterial meningitis as a risk factor 
identified during the newborn hearing 
screening period should potentially not 
have their hearing monitored throughout 
early childhood.
Grade D: 
Potentially 
Don’t 
Monitor
Low birth weight (LBW) (≤1500 g)
Outcomes of the systematic literature review: One high 
quality cohort study was identified in the systematic lit-
erature review which monitored hearing in children with 
LBW [21]. Of the 224 children included in this study, six 
(2.7%) developed a postnatal hearing loss. All six children 
had other contributing risk factors including the admin-
istration of aminoglycosides. Therefore, the development 
of the hearing loss may be a result of the other risk fac-
tors and not LBW.
Outcomes of the analysis of Queensland’s targeted sur-
veillance program: Analysis of Queensland’s targeted sur-
veillance program provided evidence against monitoring 
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children with LBW as a risk factor. Of the children iden-
tified with a postnatal hearing loss, 7.1% (4/56) had LBW 
as a risk factor. However, yield calculations for children 
with LBW who had completed their appointment series 
was only 0.4% (4/905). One of these four children devel-
oped a permanent conductive hearing loss following re-
current otitis media. Formal analysis using chi-squared 
revealed a significant negative relationship between LBW 
and postnatal hearing loss. Further analysis using logistic 
regression analysis revealed that children with LBW as a 
risk factor were one-tenth more likely to develop a post-
natal hearing loss than those with normal birth weight 
(>1500 g) (OR: 0.14; 95% CI: 0.05–0.39). 
Recommendation (e): Children with LBW as 
a risk factor should not have their hearing 
monitored throughout early childhood.
Grade E: 
Don’t 
Monitor
Severe asphyxia at birth [convulsions/ hypoxic is-
chemic encephalopathy (HIE)/ persistent pulmo-
nary hypertension of the newborn (PPHN)]
Outcomes of the systematic literature review: One high 
quality cohort study was identified in the systematic litera-
ture review that monitored hearing in children with PPHN 
[22]. Of the 40 children included in the study, four (10%) de-
veloped a postnatal hearing loss. Several other studies were 
also identified that reported on children with severe asphyxia 
who developed a postnatal hearing loss. However, predomi-
nantly these were case studies only, with the majority of chil-
dren with severe asphyxia who developed a postnatal hear-
ing loss having other contributing risk factors [13,14,23–25].
Outcomes of the analysis of Queensland’s targeted sur-
veillance program: Evidence provided from analysis of 
Queensland’s targeted surveillance program was incon-
clusive. For children diagnosed with a postnatal hearing 
loss, 16.1% (9/56) had severe asphyxia as a risk factor. Al-
though yield of postnatal hearing loss in children with se-
vere asphyxia who had completed their surveillance ap-
pointments was 4.1% (9/217), there was no significant 
correlation found between severe asphyxia and postnatal 
hearing loss on further formal analysis.
Recommendation (f): There is insufficient 
evidence to support or oppose monitoring 
hearing in children with severe asphyxia.
Grade C: 
Lack of 
Evidence
Craniofacial anomalies e.g., cleft palate (excluding 
cleft lips and skin tags)
Outcomes of the systematic literature review: Two stud-
ies were identified in the systematic literature review that 
addressed the risk factor of craniofacial anomalies. The 
first study [14] reported that two of 23 children (8.7%) 
with a postnatal hearing loss had craniofacial anomalies 
as a risk factor. The second study [15] examined hearing 
loss in children with preauricular skin tags and pits in iso-
lation and in combination with other risk factors. From the 
637 children included in this study, one child (0.2%) de-
veloped a postnatal hearing loss. This child also had Bran-
chio-oto-renal syndrome in addition to preauricular skin 
tags and pits. The authors recommended that children with 
preauricular skin tags and pits in isolation do not need to 
have their hearing monitored throughout early childhood.
Outcomes of the analysis of Queensland’s targeted sur-
veillance program: Analysis of Queensland’s targeted sur-
veillance program provided support in favor of monitoring 
children with craniofacial anomalies. For children diag-
nosed with a postnatal hearing loss, 17.9% (10/56) had 
craniofacial anomalies as a risk factor. Yield calculations 
for children who had completed their appointment series 
was 5.2% (10/191). Further analysis of these children re-
vealed a positive significant correlation between crani-
ofacial anomalies and postnatal hearing loss [χ2(1)=5.4, 
p=0.020]. Logistic regression analysis also revealed that 
children with craniofacial anomalies were more than two 
times more likely to develop a postnatal hearing loss than 
those without craniofacial anomalies (OR: 2.61; 95% CI: 
1.19–5.70). 
Recommendation (g): Children with 
craniofacial anomalies (excluding ear pits 
and skin tags) as a risk factor should have 
their hearing monitored throughout early 
childhood.
Grade A: 
Monitor
Hyperbilirubinemia levels ≥450 µmol/L (term) or 
≥340 µmol/L (preterm)
Outcomes of the systematic literature review: One case 
report only was identified through the systematic litera-
ture review on a child with hyperbilirubinemia who de-
veloped a postnatal hearing loss [13]. This child had other 
contributing risk factors including family history. There-
fore, the development of postnatal hearing loss cannot 
solely be attributed to hyperbilirubinemia.
Outcomes of the analysis of Queensland’s targeted sur-
veillance program: There was limited evidence provided 
by analysis of Queensland’s targeted surveillance program, 
with 3.6% (2/56) of children with a postnatal hearing loss 
having hyperbilirubinemia as a risk factor. Yield was cal-
culated at 1.4% (2/147) for children who had completed 
their appointment series only. There was no significant 
correlation found between hyperbilirubinemia and post-
natal hearing loss on further formal analysis. 
Recommendation (h): Children with 
hyperbilirubinemia as a risk factor 
should potentially not have their hearing 
monitored throughout early childhood.
Grade D: 
Potentially 
Don’t 
Monitor
Proven/suspected congenital infection of the baby 
(toxoplasmosis, rubella, CMV, herpes, syphilis)
Outcomes of the systematic literature review: Results 
from the systematic literature review revealed informa-
tion on the congenital infections of CMV and toxoplas-
mosis only. For CMV, studies reported on children who 
were either asymptomatic, symptomatic, or both, and a 
range of results for the proportion of the cohort who de-
veloped a postnatal hearing loss was identified. For chil-
dren with asymptomatic CMV, the proportion that devel-
oped a postnatal hearing loss ranged from 1.3% [26] to 
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5.6% [27] of the cohort. For children with symptomatic 
CMV who developed a postnatal hearing loss, the propor-
tion ranged from 5.7% [28] to 14.4% [29] of the cohort.
For toxoplasmosis, the literature search identified a sys-
tematic literature review [30] that addressed toxoplasmo-
sis exposure and sensorineural hearing loss. The outcomes 
of this study found that there was no evidence associat-
ing neonatal toxoplasmosis with postnatal hearing loss.
Outcomes of the analysis of Queensland’s targeted sur-
veillance program: Limited evidence was provided by anal-
ysis of the targeted surveillance program in Queensland. 
For children identified with a postnatal hearing loss, 3.6% 
(2/56) had congenital infection as a risk factor. The yield 
calculation for children with the risk factor congenital infec-
tion who had completed their appointment series was 3.7% 
(2/54). Despite congenital infection having had a notable 
yield of children developing a postnatal hearing loss, there 
was no significant correlation found between this risk fac-
tor and postnatal hearing loss on further statistical analysis.
Recommendation (i): Within the risk factor 
of congenital infection, children with CMV 
as a risk factor should have their hearing 
monitored throughout early childhood; and 
children with toxoplasmosis as a risk factor 
should not have their hearing monitored 
throughout early childhood. There is 
insufficient evidence to support or oppose 
monitoring hearing in children with rubella, 
herpes, or syphilis.
Grade C: 
Lack of 
Evidence
Professional concern
Outcomes of the systematic literature review: The gen-
eral risk factor ‘professional concern’ has not been explic-
itly reported on in the literature. However, there are other 
risk factors that may be incorporated under the umbrel-
la of professional concern which have been reported. Ex-
amples of these other risk factors include cerebral hemor-
rhage, ototoxic therapy, and gestational age of <33 weeks 
[13,14,18]. However, as these cases were drawn from stud-
ies which reported on children with hearing loss only as 
well as children with other complex risk factors, it was dif-
ficult to establish the exact relationship between these risk 
factors and postnatal hearing loss.
Outcomes of the analysis of Queensland’s targeted sur-
veillance program: The risk factor ‘professional concern’ 
is used in Queensland to encompass medical conditions 
that present between birth and 28 days, are not appro-
priate for the other risk factor categories, and where the 
treating doctor has concerns for the child’s hearing. Pro-
fessional concern covers a broad range of medical issues 
including chemotherapy or human immunodeficiency vi-
rus (HIV) during pregnancy. For the 78 children referred 
to the targeted surveillance program with the risk factor 
of professional concern, no children (nil yield) had devel-
oped a postnatal hearing loss. No significant correlation 
was found on further analysis between postnatal hearing 
loss and professional concern.
Recommendation (j): Children with 
professional concern as a risk factor 
identified during the newborn hearing 
screening period should potentially not 
have their hearing monitored throughout 
early childhood.
Grade D: 
Potentially 
Don’t 
Monitor
Directions for future research
This research has identified significant gaps in the cur-
rent literature which need further investigation. Particu-
larly, it has emphasised the need for further research in 
order to firmly establish the relationship between risk fac-
tors and postnatal hearing loss. Of the above risk factors, 
there was convincing evidence for recommendations for 
only three. Children with family history and craniofacial 
anomalies as a risk factor should have their hearing mon-
itored (Grade A) and children with LBW as a risk factor 
should not (Grade E). Although there was some evidence 
to suggest that children with syndrome or prolonged ven-
tilation as a risk factor may potentially require monitor-
ing (Grade B), there is currently insufficient evidence to 
draw definitive conclusions regarding this recommenda-
tion. Similarly, the current evidence for bacterial menin-
gitis, hyperbilirubinemia, and professional concern leans 
towards potentially not monitoring (Grade D); however, 
again the evidence is lacking and not conclusive. Current 
research on the risk factors of severe asphyxia and con-
genital infection is inconclusive and/or conflicting with no 
conclusions able to be drawn (Grade C). In general, there 
is a lack of large cohort studies that follow children with an 
individual risk factor to determine the likelihood of such 
children developing a postnatal hearing loss.
Another area which requires investigation is the suitability 
of risk factor monitoring compared to other post-neonatal 
care pathways that may be more effective in detecting post-
natal hearing loss. Other post-neonatal care pathways that 
could be used in conjunction with, or instead of, risk fac-
tor monitoring include introducing neonatal CMV and/or 
genetic screening, universal preschool and school screen-
ing programs, referral for an assessment due to parent/pro-
fessional concerns, and the health visitor distraction test 
(HVDT) [2,9,31,32]. Although these assessment pathways 
have been reported in the literature, to date there has been 
no study that has compared the use of these alternative 
models to risk factor monitoring. To establish the most ef-
fective way to detect postnatal hearing loss in early child-
hood, further large-scale longitudinal studies are required 
which assess children both with and without risk factors.
Summary and Conclusion
This study has listed recommendations for inclusion/ex-
clusion of risk factors to be incorporated within risk fac-
tor registries used by targeted surveillance programs. Con-
vincing evidence was found for three risk factors only. The 
risk factors of family history and craniofacial anomalies 
should be included in a risk factor registry and children 
with these risk factors should have their hearing monitored 
throughout early childhood. In contrast, the risk factor of 
LBW should not be incorporated in a risk factor registry 
and children with LBW in isolation do not need to have 
their hearing monitored. Children with the risk factors 
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of syndrome and prolonged ventilation should potential-
ly have their hearing monitored, although the evidence 
is not definitive. Equally, children with the risk factors 
of bacterial meningitis, hyperbilirubinemia, and profes-
sional concern may not need to have their hearing mon-
itored; however, again the evidence is not definitive. The 
evidence for severe asphyxia and congenital infection is 
inconclusive and/or conflicting. Therefore, no recommen-
dations are made for monitoring children with these risk 
factors. Although this paper has presented recommenda-
tions for risk factor registries, further large-scale, popula-
tion-based research should be conducted on children both 
with and without risk factors to establish the most effec-
tive way of detecting postnatal hearing loss in childhood.
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